Ajita S. Prabhu

Ajita S. Prabhu

Auto-generated profile, based on publicly available information

Ajita S. Prabhu

Department of Surgery, Cleveland Clinic Center for Abdominal Core Health, Cleveland Clinic Foundation, Cleveland, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
APAjita S. Prabhu
Ajita S. Prabhu
ACAlfredo Carbonell
Alfredo Carbonell
WHWilliam Hope
William Hope
JWJeremy Warren
Jeremy Warren
RHRana Higgins
Rana Higgins
MRMichael J. Rosen
Michael J. Rosen
Minimally invasive inguinal hernia repair was first described by Ger1 in 1991 using a laparoscopic technique. A seminal article by Neumayer et al concluded that open inguinal hernia repair is superior to the laparoscopic approach,2 yet laparoscopic inguinal hernia repair has developed a reputation for shorter recovery time, equivalent recurrence rates, and lower incidence of short-term and long-term pain than open Lichtenstein repair in other modern series and current international guidelines.3 Additional costs associated with the laparoscopic technique are also thought to be offset by less-easily quantified benefits such as earlier return to work.3

1 August 2017 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
APAjita S. Prabhu
Ajita S. Prabhu
EDEugene O. Dickens
Eugene O. Dickens
CCChad M. Copper
Chad M. Copper
JMJohn W. Mann
John W. Mann
JYJonathan P. Yunis
Jonathan P. Yunis
MRMichael J. Rosen
Michael J. Rosen
Robotic intraperitoneal mesh placement (rIPOM) has emerged recently as an alternative to laparoscopic intraperitoneal mesh placement (LapIPOM) for minimally invasive incisional hernia repair. We aimed to compare LapIPOM with rIPOM in terms of hospital length of stay (LOS) and 30-day postoperative complications in patients undergoing incisional hernia repair within the Americas Hernia Society Quality Collaborative. Propensity score analysis was used to compare matched groups of patients within the Americas Hernia Society Quality Collaborative undergoing LapIPOM vs rIPOM. The primary outcomes measure was hospital LOS and secondary outcomes were 30-day wound events. Four hundred and fifty-four (71.9%) patients underwent LapIPOM and 177 (28.1%) underwent rIPOM. The laparoscopic group had an increased median LOS (1 vs 0 days; interquartile range 3.00; p < 0.001). The risk of surgical site occurrence was higher in the LapIPOM group vs the rIPOM group (14% vs 5%; p = 0.001); however, surgical site occurrence requiring procedural intervention was similar between the groups (1% vs 0%; p = 1). Operative time longer than 2 hours was more common in the rIPOM group (47% vs 31%; p < 0.05). Despite longer operative times using the rIPOM approach, patients undergoing rIPOM had a significantly shorter LOS than LapIPOM, without additional risk of wound morbidity requiring intervention. Additional studies are necessary to identify the best candidates for the rIPOM approach.

1 March 2017 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
APAjita S. Prabhu
Ajita S. Prabhu
DKDavid M. Krpata
David M. Krpata
SPSharon Phillips
Sharon Phillips
LHLi-Ching Huang
Li-Ching Huang
IHIvy N. Haskins
Ivy N. Haskins
MRMichael J. Rosen
Michael J. Rosen
There is varying evidence about the use of preoperative chlorhexidine gluconate to decrease surgical site infection for elective surgery. This intervention has never been studied in ventral hernia repair, the most common general surgery procedure in the US. We aimed to determine whether preoperative chlorhexidine gluconate decreases the risk of 30-day wound morbidity in patients undergoing ventral hernia repair. All patients undergoing ventral hernia repair in the Americas Hernia Society Quality Collaborative were separated into 2 groups: 1 group received preoperative chlorhexidine scrub and the other did not. The 2 groups were evaluated for 30-day wound morbidity, including surgical site occurrence (SSO), surgical site infection (SSI), and SSO requiring procedural intervention. Statistical analysis was performed using multivariate regression analysis and propensity score modeling. Multiple factors were controlled for statistical analysis, including patient-related factors and operative factors. In total, 3,924 patients were included for comparison. After multivariate logistic regression modeling, the preoperative chlorhexidine scrub group had a higher incidence of SSOs (odds ratio [OR] = 1.34; 95% CI 1.11 to 1.61) and SSIs (OR = 1.46; 95% CI 1.03 to 2.07). After propensity score modeling, the increased risk of SSO and SSI persisted (SSO: OR = 1.39; 95% CI 1.15 to 1.70; SSI: OR = 1.45; 95% CI 1.011 to 2.072, respectively). Prehospital chlorhexidine gluconate scrub appears to increase the risk of 30-day wound morbidity in patients undergoing ventral hernia repair. These findings suggest that the generalized use of prehospital chlorhexidine might not be desirable for all surgical populations.

1 June 2018 in Surgical Clinics of North America
Verified
Journal Article
Closed access
CPClayton C. Petro
Clayton C. Petro
APAjita S. Prabhu
Ajita S. Prabhu

1 August 2023 in JAMA Surgery
Verified
Journal Article
Closed access
PDF file
RERyan C. Ellis
Ryan C. Ellis
CPClayton C. Petro
Clayton C. Petro
DKDavid M. Krpata
David M. Krpata
LBLucas R. A. Beffa
Lucas R. A. Beffa
BMBenjamin T. Miller
Benjamin T. Miller
APAjita S. Prabhu
Ajita S. Prabhu
Importance Transfascial (TF) mesh fixation in open retromuscular ventral hernia repair (RVHR) has been advocated to reduce hernia recurrence. However, TF sutures may cause increased pain, and, to date, the purported advantages have never been objectively measured. Objective To determine whether abandonment of TF mesh fixation would result in a noninferior hernia recurrence rate at 1 year compared with TF mesh fixation in open RVHR. Design, Setting, and Participants In this prospective, registry-based, double-blinded, noninferiority, parallel-group, randomized clinical trial, a total of 325 patients with a ventral hernia defect width of 20 cm or less with fascial closure were enrolled at a single center from November 29, 2019, to September 24, 2021. Follow-up was completed December 18, 2022. Interventions Eligible patients were randomized to mesh fixation with percutaneous TF sutures or no mesh fixation with sham incisions. Main Outcome and Measures The primary outcome was to determine whether no TF suture fixation was noninferior to TF suture fixation for open RVHR with regard to recurrence at 1 year. A 10% noninferior margin was set. The secondary outcomes were postoperative pain and quality of life. Results A total of 325 adults (185 women [56.9%]; median age, 33 [IQR, 50-67] years) with similar baseline characteristics were randomized; 269 patients (82.8%) were followed up at 1 year. Median hernia width was similar in the TF fixation and no fixation groups (15.0 [IQR, 12.0-17.0] cm for both). Hernia recurrence rates at 1 year were similar between the groups (TF fixation, 12 of 162 [7.4%]; no fixation, 15 of 163 [9.2%];P = .70). Recurrence-adjusted risk difference was found to be −0.02 (95% CI, −0.07 to 0.04). There were no differences in immediate postoperative pain or quality of life. Conclusions and Relevance The absence of TF suture fixation was noninferior to TF suture fixation for open RVHR with synthetic mesh. Transfascial fixation for open RVRH can be safely abandoned in this population. Trial Registration ClinicalTrials.gov Identifier:NCT03938688

1 November 2017 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
IHIvy N. Haskins
Ivy N. Haskins
DKDavid M. Krpata
David M. Krpata
MRMichael J. Rosen
Michael J. Rosen
APArielle J. Perez
Arielle J. Perez
LTLuciano Tastaldi
Luciano Tastaldi
APAjita S. Prabhu
Ajita S. Prabhu
Online surgeon ratings are viewed as a measure of physician quality by some consumers. Nevertheless, the correlation between online surgeon ratings and surgeon quality metrics remains unknown. The purpose of this study was to investigate the association between online surgeon ratings and hernia-specific quality metrics. The Americas Hernia Society Quality Collaborative (AHSQC) is recognized by the Centers for Medicaid and Medicare as a Quality Clinical Data Registry (QCDR) that reports risk-adjusted quality metrics for hernia surgeons. All surgeons who input at least 10 patients into the AHSQC and had both a HealthGrades.com and Vitals.com rating were included in the analysis. The association of surgeons' average, risk-adjusted QCDR quality score with their online ratings was investigated using a linear regression model. A total of 70 surgeons met inclusion criteria. The median number of evaluations each surgeon received on HealthGrades.com was 7; the median number of evaluations each surgeon received on Vitals.com was 3. There was a statistically significant correlation between the ratings surgeons received on HealthGrades.com and those that they received on Vitals.com (p < 0.0001). However, there was no correlation between surgeon ratings on either HealthGrades.com or Vitals.com and surgeon QCDR quality scores (p = 0.37 and p = 0.18, respectively). Online physician rating systems correlate with one another, but they do not accurately reflect physician quality. The development of specialty-specific, risk-adjusted quality measures and appropriate public dissemination of this information may help patients make more informed decisions about their health care.